Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Mar 21, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- AHRQ Announces Interest in Primary Care Research
(NOT-HS-22-011)
Agency for Healthcare Research and Quality
General Notices
- Notice of NCCIH Technical Assistance Webinar for RFA-AT-22-001, "NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional)
(NOT-AT-22-016)
National Center for Complementary and Integrative Health
- NIDA Challenge "CODE (Cause of Death Elucidated) in Drug Overdose: Rapid and portable cause of death detection technologies to improve drug overdose-related mortality counts"
(NOT-DA-22-054)
National Institute on Drug Abuse
- Findings of Research Misconduct
(NOT-OD-22-095)
Office of the Director, NIH
- Findings of Research Misconduct
(NOT-OD-22-096)
Office of the Director, NIH
- Findings of Research Misconduct
(NOT-OD-22-097)
Office of the Director, NIH
- Findings of Research Misconduct
(NOT-OD-22-098)
Office of the Director, NIH
- Request for Information (RFI): Inviting comments to inform the National Institutes of Health (NIH) on the intersection of the SARS-CoV-2/COVID-19 pandemic and the health of women
(NOT-OD-22-092)
Office of Research on Women's Health
- Request for Information (RFI): Challenges and Opportunities in Elucidating the Human Virome
(NOT-RM-22-010)
Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
- Notice of Cancellation of RFA-DK-22-005, Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
(NOT-DK-22-019)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change to update Eligibility Information under RFA-FD-22-010; "Revision Applications - Development and Maintenance of the Animal Feed Regulatory Program Standards Flexible Funding Model Compliance and Enforcement Expansion Supplement (U18)"
(NOT-FD-22-009)
Food and Drug Administration
- Notice of Correction to Eligibility and Application Types in RFA-HL-23-006, " Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
(NOT-HL-22-013)
National Heart, Lung, and Blood Institute
- Notice of Change to PAR-21-357 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
(NOT-NS-22-075)
National Institute of Neurological Disorders and Stroke
- Notice to Extend Expiration Date for PAR-20-128: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
(NOT-OD-22-085)
Office of the Director, NIH
- Notice to Extend Expiration Date for PAR-20-129: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
(NOT-OD-22-086)
Office of the Director, NIH
- Notice to Extend Expiration Date for PAR-20-130: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
(NOT-OD-22-087)
Office of the Director, NIH
- Notice of Change to RFA-OD-22-004, Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)
(NOT-OD-22-094)
Office of Disease Prevention
- Notice of Change to Correct Eligibility Information under RFA-RM-22-008; "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)"
(NOT-RM-22-011)
Office of Strategic Coordination (Common Fund)
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for An Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
(NOT-HG-22-012)
National Human Genome Research Institute
Notices of Special Interest
- Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data.
(NOT-CA-22-056)
National Cancer Institute
National Institute of Environmental Health Sciences
- Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
(NOT-TR-22-023)
National Center for Advancing Translational Sciences
Funding Opportunities
- NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
(PAR-22-133)
National Institute on Drug Abuse
- NIAID Research Education Program (R25 Clinical Trial Not Allowed)
(PAR-22-134)
National Institute of Allergy and Infectious Diseases
- Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
(PAR-22-137)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute of Environmental Health Sciences
Office of Research on Women's Health
- Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
(PAR-22-138)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute of Environmental Health Sciences
Office of Research on Women's Health
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
(PAR-22-139)
National Cancer Institute - Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
(PAR-22-140)
National Cancer Institute
- NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
(PAR-22-141)
National Eye Institute
- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed)
(RFA-DA-23-004)
National Institute on Drug Abuse
- Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed)
(RFA-DA-23-009)
National Institute on Drug Abuse
- Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional)
(RFA-DA-23-010)
National Institute on Drug Abuse
- KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
(RFA-DK-21-033)
National Institute of Diabetes and Digestive and Kidney Diseases
- NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)
(RFA-DK-22-004)
National Institute of Diabetes and Digestive and Kidney Diseases
- National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50) (Clinical Trial Optional)
(RFA-HD-23-011)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
(RFA-HL-23-007)
National Heart, Lung, and Blood Institute
National Cancer Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
- Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed)
(RFA-LM-22-001)
National Library of Medicine
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).